Insider Transactions in Q4 2023 at Point Biopharma Global Inc. (PNT)
Insider Transaction List (Q4 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 27
2023
|
Yael Margolin Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,710
-100.0%
|
-
|
Dec 27
2023
|
David Charles Lubner Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,600
-100.0%
|
-
|
Dec 26
2023
|
Jonathan R. Goodman Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
41,872
-100.0%
|
-
|
Dec 26
2023
|
David Charles Lubner Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
35,400
-90.77%
|
-
|
Dec 26
2023
|
Rajesh Malik Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,700
-100.0%
|
-
|
Dec 26
2023
|
Gerald L. Hogue Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
21,596
-100.0%
|
-
|
Dec 22
2023
|
Joe A. Mccann Chief Executive Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
3,494,153
-100.0%
|
-
|
Dec 22
2023
|
Joe A. Mccann Chief Executive Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
2,160
-100.0%
|
-
|
Dec 22
2023
|
Allan C Silber Executive Chairman |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
8,727,975
-100.0%
|
-
|
Dec 22
2023
|
Neil E. Fleshner Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
233,529
-100.0%
|
-
|
Dec 22
2023
|
Neil E. Fleshner Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
2,773,045
-100.0%
|
-
|
Dec 18
2023
|
Bvf Partners L P |
SELL
Open market or private sale
|
Direct |
17,161,278
-100.0%
|
$205,935,336
$12.45 P/Share
|
Nov 06
2023
|
Joe A. Mccann Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
120,000
-3.32%
|
-
|
Nov 03
2023
|
Allan C Silber Executive Chairman |
SELL
Bona fide gift
|
Indirect |
500,000
-92.92%
|
-
|
Oct 31
2023
|
Neil E. Fleshner Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
250,000
-8.27%
|
-
|